ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Miss Nina: Cerebral palsy

Patient basic information Patient: Ms. Nina (Nina White) Nationality: Switzerland Diagnosis: Cerebral vascular atrophy Clinic: Hospital of the University of Hong Kong, Shenzhen Hospital Treatment: Blood stem cell transplant + chemotherapy Household days: 142 days Treatment cost: approximately 290,844 yuan Treatment effect: Rehabilitation from hospital After arriving at the Shenzhen Hospital of the University of Hong Kong, for the first time, the International Medical Services team arranged multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided full translation, accompaniment and landing services. During the treatment process, the team of experts at the Shenzhen Hospital of the University of Hong Kong used a comprehensive set of blood stem cell transplants + chemotherapy, during which the medical team closely monitored the patient's indicators, dynamic adjustment programs.

After 142 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached the standard of discharge. Treatment results. Patients were finally discharged from the hospital.

When discharged, the medical team developed a detailed return follow-up and rehabilitation plan for them, and continued to track recovery through a remote follow-up system. 'Ladies Nina, experts have criticized this case as a typical case of cross-border suspected seriousness. The University of Hong Kong Shenzhen Hospital, based on a multidisciplinary collaborative mechanism, has developed a blood stem cell transplant + chemotherapy program for cerebral vascular degeneration, which reflects the comprehensive strength of Chinese hospitals in the field of suspected disease diagnosis and is a shorthand for the regulation of international visitor medical services.

斯威士兰,脑血管畸形,香港大学深圳医院,国际医疗,来华就医,中国医疗